Melanoma – Wide Local Excision


Goals/Objectives

  • Pathogenesis

  • Indications

  • Techniques

Melanoma and Cutaneous Malignancies

Kelly M. McMasters
Marshall M. Urist

From Townsend CM: Sabiston Textbook of Surgery, 19th edition (Saunders 2012)

The ABCDEs of melanoma are used to guide the decision about performing a biopsy – a symmetrical irregular b orders, variable shades of c olor, d iameter greater than 6 mm, and e volution, or change over time. However, many melanomas do not follow these rules. Amelanotic melanomas are not pigmented and may present as a raised pink or flesh-colored skin lesion. A high index of clinical suspicion is needed, and particular attention should be paid to any history of change in a lesion. If a patient presents with a skin lesion that has changed in size, color, or shape, and/or is itching or bleeding, a biopsy should be performed. To tell a patient that it will just be observed means that it will be ignored. There should be a low threshold for performance of biopsy. Fortunately, locally advanced melanomas are now infrequently encountered, given the increased awareness of this disease ( Figure 53-1-1 ).

F igure 53-1-1, Locally advanced melanomas.

Biopsy

Primary care physicians, as well as dermatologists and surgeons, should be trained to perform a skin biopsy. There are three basic types of skin biopsy – excisional, incisional (including punch biopsy), and shave biopsy. An excisional biopsy is the most appropriate and prudent method of diagnosing and completely removing a pigmented skin lesion in most cases. Most patients who have a pigmented lesion that is of concern want it completely removed in any case, even if it is benign. Using local anesthesia, a narrow margin excision is performed, which includes subcutaneous fat to get a full-thickness biopsy, and the defect is closed with sutures. Attention should be paid to the orientation of the excision, because a fusiform excision should be oriented in such a way as to prepare for the possibility that the lesion is a melanoma and may require WLE. Specifically, a longitudinal orientation on the extremities is best and, in other areas, consideration should be given to the orientation that would allow closure with the least tension and best cosmetic outcome in case wide excision is needed. Therefore, excisional biopsy is best for most small pigmented lesions.

For larger lesions, it may be appropriate first to get a tissue diagnosis prior to performing complete excision; this is accomplished by a full-thickness incisional biopsy. The simplest way to perform an incisional biopsy is by use of a punch biopsy. A punch biopsy is performed using a disposable instrument that removes a cylinder of skin and subcutaneous tissue (2 to 8 mm in diameter) by simply twisting the instrument into the anesthetized skin, followed by closure with one or two simple sutures ( Figure 53-1-2 ). Punch biopsies of at least 4 mm should be performed, because a 2-mm punch often does not provide adequate tissue for pathologic evaluation. The punch biopsy should be performed through the thickest area(s) of the lesion, and multiple punch biopsies can be performed to sample larger lesions. Shave biopsies are frequently performed by dermatologists and are appropriate for many nonpigmented skin lesions. This is a good way to diagnose squamous cell and basal cell carcinoma. A shave biopsy is performed by elevating the skin lesion with forceps or inserting a small needle beneath the lesion, followed by shaving the lesion with a razor blade or scalpel. Hemostasis is achieved using topical agents such as ammonium chloride or by electrocautery. The patient then treats the area with topical antibiotic ointment and it is allowed to heal by secondary intention. Because a shave biopsy is quick and simple to perform and does not require sutures, it is a popular method of biopsy. However, shave biopsy should generally be discouraged for pigmented lesions, because if a melanoma is diagnosed, a shave biopsy may transect directly through the melanoma and not allow an accurate assessment of tumor thickness as the base of the lesion is cauterized. Therefore, shave biopsy should not be used when melanoma is suspected. To circumvent this problem, dermatologists often perform deep shave or saucerization biopsies, which completely remove the lesion down to subcutaneous fat if there is any concern for melanoma. In the hands of experienced clinicians, this can be an effective biopsy technique. All pigmented lesions should be sent for pathologic evaluation. Ablation of pigmented skin lesions using cryotherapy, cautery, or lasers should be specifically discouraged; there are many examples of disastrous delays in diagnosis as a result of such practices.

F igure 53-1-2, Disposable instrument used for punch biopsy.

Pathology

Over the past several years, there has been a dramatic increase in the diagnosis of equivocal lesions whose biologic behavior cannot be predicted with absolute certainty. There is a spectrum that ranges from mild to severe dysplasia to atypical melanocytic proliferation to melanoma in situ to early invasive melanoma. Part of the increase in the incidence of melanoma almost certainly results from a lower threshold on the part of pathologists to diagnose such equivocal lesions as melanoma because of the potential consequences of a missed diagnosis of melanoma. It is now common for a pathology report to contain a long description that essentially states that the lesion may be anything from a severely dysplastic nevus to early invasive melanoma. In such cases, the prudent decision is to treat such lesions as an early invasive melanoma with a 1-cm margin WLE. Melanoma in situ is considered a premalignant precursor lesion that has a significant likelihood of progression to invasive melanoma. Because it does not invade beyond the basement membrane, it does not have access to blood vessels and lymphatics and does not generally have metastatic potential.

Histologically, invasive cutaneous melanoma is divided into four major types based on growth pattern and location. These forms are lentigo maligna melanoma, superficial spreading melanoma, acral lentiginous melanoma, and nodular melanoma. Melanomas arise as proliferations of melanocytes in the basal layer of the skin. As they multiply, these cells expand radially in the epidermis and superficial dermal layer, termed the radial growth phase. With time, the growth begins in a vertical direction as the skin lesion may become palpable, the so-called vertical growth phase. Nodular melanomas are an exception to this pattern, wherein the vertical growth phase is present early in tumor development. The vertical growth phase allows invasion into the deeper layers of the skin, where the tumor may achieve metastatic potential by invasion of blood and lymphatic vessels.

The histologic subtype of melanoma is not, in general, a major factor in prognosis; tumor thickness, ulceration, and other factors determine the prognosis. However, some histologic subtypes are more likely to be detected at a more advanced stage. Lentigo maligna melanoma occurs most commonly on the face of older individuals with sun-damaged skin and presents as a flat, dark, variably pigmented lesion, with irregular borders and a history of slow development ( Figure 53-1-3 ). Lentigo maligna melanomas may become large prior to diagnosis, because the slow progression may escape the patient's notice. Overall, the prognosis of lentigo maligna melanomas is better than for the other histopathologic types because of the often superficial nature of these tumors. However, lentigo maligna melanomas can pose challenging management problems because of their propensity to develop in cosmetically challenging areas (e.g., face), and the fact that the histologic extent of the lesion may extend well beyond the clinically apparent borders of the pigmented lesion. Thus, achieving negative margins may be challenging. Before embarking on complex tissue flaps for closure, it is prudent to ensure negative margins. This may necessitate delaying the closure until the final pathology report indicates negative margins of excision.

F igure 53-1-3, Lentigo maligna melanomas.

The most common histologic type is superficial spreading melanoma ( Figure 53-1-4 ). It is not necessarily associated with sun-exposed skin. As the name suggests, superficial spreading melanoma initially appears as a flat pigmented lesion growing in the radial dimension. If allowed to progress, these melanomas develop a vertical growth phase and invade more deeply into the skin.

F igure 53-1-4, Superficial spreading melanomas.

Acral lentiginous melanoma (ALM) is classified by its anatomic site of origin. These tumors develop in the subungual areas, beneath the fingernails and toenails, and on the palms of the hand and soles of the feet ( Figure 53-1-5 ). This is the most common type of melanoma in black patients. The histologic appearance of ALMs is similar to melanomas arising on the mucous membranes. The diagnosis is often made at an advanced stage, which accounts for the poor prognosis of these tumors in general. Subungual acral lentiginous melanomas are often mistaken for subungual hematomas, leading to a delay in diagnosis. A key feature distinguishing a subungual melanoma from a subungual hematoma is that for subungual hematoma, the pigment should migrate distally with growth of the nail. Biopsy of subungual melanomas can be accomplished by performing a digital block with local anesthesia and removing the nail or performing a punch biopsy through the nail itself.

F igure 53-1-5, Acral lentiginous melanoma.

Nodular melanomas are raised papular lesions that develop a vertical growth pattern early in their course ( Figure 53-1-6 ). These melanomas often have a poor prognosis because of greater average tumor thickness and frequent ulceration.

F igure 53-1-6, Nodular melanoma.

Desmoplastic melanoma is a specific type of amelanotic melanoma, which commonly arises on the head and neck. Desmoplastic melanomas often exhibit neurotropism and have a greater propensity for local recurrence, with a decreased risk of nodal metastasis.

References

  • 1. Tran KT, Wright NA, Cockerell CJ: Biopsy of the pigmented lesion – when and how. J Am Acad Dermatol 2008; 59: pp. 852-871.
  • 2. Piris A, Mihm MC: Progress in melanoma histopathology and diagnosis. Hematol Oncol Clin North Am 2009; 23: pp. 467-480.

Melanoma

Stephan Ariyan
Aaron Berger

From Neligan PC, et al: Plastic Surgery, 3rd Edition (Saunders 2012)

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here